Sarepta Therapeutics | SRPT - PE Price to Earnings



Sarepta Therapeutics reported 27.27 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
Acadia Pharmaceuticals 16.19 4.11 Jun/2025
Agios Pharmaceuticals 2.88 0.36 Jun/2025
Amgen 12.51 28.7 Jun/2025
Biogen 12.41 0.17 Jun/2025
BioMarin Pharmaceutical 15.13 7.26 Jun/2025
Daiichi Sankyo 21.68 5.55 Jun/2025
Eli Lilly 37 7.55 Jun/2025
Gilead Sciences 15.39 279.48 Jun/2025
Incyte 14.77 134.3 Jun/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Moderna 27.22 14.51 Jun/2023
Neurocrine Biosciences 42.61 5.9 Jun/2025
Pfizer 9.12 8.86 Jun/2025
PTC Therapeutics 6.47 0.7 Jun/2025
Regeneron Pharmaceuticals 13.35 3.19 Jun/2025
Roche Holding 19.32 1.87 Jun/2024
Sanofi 16.47 6.85 Jun/2025
Sarepta Therapeutics 27.27 0 Jun/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Vertex Pharmaceuticals 27.81 3.5 Jun/2025